ACP Recommends Bisphosphonates for Initial Treatment of Osteoporosis
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults.
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults.
SGLT2 inhibitors are associated with lowest probability for adverse outcomes followed by GPL1 receptor agonists and metformin
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Tzield is anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Maternal obesity with excessive weight gain linked to increased risk for ADHD in offspring vs normal weight without excessive weight gain.
This study builds on recent research indicating that prescribing NPH insulin may be reasonable for older patients with concerns about medication costs, particularly when it is used in combination with prandial insulin.
Hormone therapy remains the most effective treatment for hot flashes and genitourinary syndrome of menopause.
A bipartisan bill was introduced to the Senate to reduce the soaring price of insulin for patients on both Medicare and private insurance plans.
Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.
New guidelines for hospitalized patients with diabetes emphasize goal-directed glycemic management, continuous glucose monitoring, and use of insulin pumps to improve outcomes and reduce the likelihood of readmission.